Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | 13 341 | déclaré | 25 févr. 2026 | tx 65+204 325−26 579 |
| CYBRA CORP | 5 000 | déclaré | 19 nov. 2008 | tx 1+5 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 25 févr. 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1 250 | 0.00 USD | |
| 25 févr. 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 675 | 50.69 USD | |
| 25 févr. 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 1 250 | 0.00 USD | deriv |
| 24 févr. 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 603 | 51.35 USD | |
| 24 févr. 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1 125 | 0.00 USD | |
| 24 févr. 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 671 | 0.00 USD | |
| 24 févr. 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 750 | 0.00 USD | |
| 24 févr. 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 369 | 50.86 USD | |
| 24 févr. 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1 250 | 0.00 USD | |
| 24 févr. 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 1 125 | 0.00 USD | deriv |
| 24 févr. 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 1 250 | 0.00 USD | deriv |
| 24 févr. 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 750 | 0.00 USD | deriv |
| 18 févr. 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3 000 | 0.00 USD | deriv |
| 18 févr. 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 13 500 | 0.00 USD | deriv |
| 25 sept. 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 1 875 | 0.00 USD | |
| 25 sept. 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 840 | 46.21 USD | |
| 25 sept. 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 1 875 | 0.00 USD | deriv |
| 10 sept. 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1 875 | 0.00 USD | deriv |
| 05 mars 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 577 | 33.05 USD | |
| 05 mars 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 314 | 33.05 USD | |
| 05 mars 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 577 | 33.05 USD | |
| 21 févr. 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 1 875 | 0.00 USD | |
| 21 févr. 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 927 | 39.15 USD | |
| 23 févr. 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1 250 | 0.00 USD | |
| 22 févr. 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1 250 | 0.00 USD |